Federal Requirements
- DEA numbers
DEA #s have 2 letters followed by 7 numbers
- The 1rst letter shows you the type of prescriber (A, B, F for MD; M for mid-level practitioners like FNP or PA)
- The 2nd letter should be the first letter of the doctor’s last name
- Add the 1st, 3rd, and 5th numbers
- Add the 2nd, 4th, and 6th numbers and multiply by 2
- Add the 2 sums of the numbers together
- The last digit in the total sum should match the last number in the DEA number
In order to prescribe schedule II-V drugs you need a DEA number
DEA number is required for all physicians prescribing medications
- Schedules of controlled substances/refill allowances/transfer of prescriptions
Schedule I (CI): high potential for abuse and are not accepted for medical purposes in the US. Ex: heroin
Schedule II (CII): high potential for abuse but are accepted for medical purposes. Non-refillable without an MD order and must be locked up behind pharmacy counter. Ex: fentanyl
Schedule III-V (CIII-CV): Less potential for abuse; may be refilled up to 5 times within 6 months of the date the prescription was first issued
- Emergency or partial refill are acceptable for CIII-CV in certain circumstances
- You can only transfer a prescription to another pharmacy once
- Recall classifications
Class 1: Products that could cause serious harm or prove \n fatal \n Class 2: Products found to cause a temporary health \n problem or pose a slight threat of serious harm \n Class 3: Products that may have a minor defect or other \n condition that would not harm the patient
- 4 DEA forms
DEA 222: purchasing and returning of outdated CII drugs
DEA 41: the destruction of, or return of damaged controlled substances
DEA 224: for a pharmacy to dispense controlled substances
DEA 225: manufacture or distribute controlled substances
Top 10 Federal Laws
- 1906 Pure Food and Drug Act - Enacted to stop the sale of inaccurately labeled \n drugs/Manufacturers were required to: Provide truthful information on the label before a drug was sold and to prove the drug’s effectiveness
- 1938 Food, Drug, and Cosmetic Act - Added Cosmetics to the Food and Drug Act/Required drug companies to include directions to the consumer regarding use of a drug, and required package inserts/All addictive substances had to be labeled: “Warning: May be habit forming”
- 1951 Durham Humphrey Amendment - Distinguishes legend (prescription) drugs from OTC drugs/Requires: “Caution: Federal law prohibits dispensing without a prescription”
- 1962 Kefauver-Harris Amendment - For safety and effectiveness of all new drugs on the market/ Burden put on manufacturers to ensure “good manufacturing practice”(GMP)
- 1970 Comprehensive Drug Abuse Prevention and Control Act - The DEA was created and controlled substances placed into Schedules I-V based on abuse potential
- 1970 Poison Prevention Packaging Act - Requires Childproof packaging on drugs except drugs used in emergency situations such as sublingual nitroglycerin
- 1990 Omnibus Budget Reconciliation Act (OBRA) - Requires pharmacist to attempt or offer to counsel patients with Medicare or Medicaid on all new prescriptions, at time of purchase (elderly mostly affected)
- 1996 HIPAA - rules and regulations regarding the privacy and security of patient health information
- 2000 Drug Addiction Treatment Act - Physicians can prescribe controlled substances to persons suffering from opioid addiction
- 2006 Combat Methamphetamine Epidemic Act - Limits the purchase of pseudoephedrine. Only a licensed pharmacist or technician may dispense, sell, or distribute this drug and it is limited to 3.6 g per calendar day, 9g per 30 days from a retailer, 7.5 g per 30 days by mail order
Top 10 Pharmacy Reference Books
- Drug Facts and Comparison \n ◦ quick, accurate reference of drug facts and drug comparison \n ◦ •Most up-to-date reference available \n ◦ •Each drug listing in the F&C includes the following information: Indications, dosage strengths, dosage forms, sizes, and manufacturers
- Physician Desk Reference (PDR) \n ◦ Found in all prescribers’ offices and pharmacies \n ◦ Updated annually \n ◦ Provides a complete description of the drug, including its chemical structure and study results \n ◦ Only FDA-approved drugs \n ◦ •D manufacturer contact information, such as addresses and phone numbers
- Red Book \n ◦ Drug costs \n ◦ Retail setting \n ◦Includes tables showing pharmacy calculations and dosing instructions translated into Spanish
- Orange Book \n ◦ Lists all FDA-approved drug products with therapeutic equivalence \n ◦ Also includes discontinued drug products, orphan product designations, approvals list \n ◦ Updated annually
- United States Pharmacopoeia- National \n Formulary (USP-NF) \n ◦ Presents the official standards of the FDA \n ◦ Serves as a guide to the specifications that are required for \n pharmaceutical manufacturing and quality control (ex. tests, \n procedures, acceptance criteria)
- United States Pharmacopoeia (USP) \n ◦ Comprehensive source of information on compounding products, ingredients, their \n safety, and products used to treat specific medical conditions \n ◦ •Also includes most recent sterile preparation guidelines for USP
- American Hospital Formulary Service Drug Information \n ◦ Hospital setting; provides drug monographs that provide \n detailed information (ex. on-and off-label uses, specific dosage \n information, mechanism of action) except cost \n ◦ List of approved drugs stocked by a pharmacy (also a list \n of drugs covered by an insurance company)
- Ident-A-Drug \n ◦ Tablet and capsule identifications \n ◦ More than 7000 listings \n ◦ Listed by identifiable codes, shapes, and whether the tablet is scored
- Micromedex \n ◦ Online and mobile application that can be used by physicians, pharmacists and \n nurses \n ◦ Information is provided through several different software programs that can be \n purchased, including: comprehensive drug details: DRUGDEX \n ◦ FDA-approved drugs: PDR compilation of package inserts
- Trissel’s Handbook on Injectable Drugs \n ◦ Mostly used in the hospital setting \n ◦ Provides information on the compatibility of various agents given parenterally \n ◦ Monographs discuss products, administration, stability, and compatibility with infusion \n solutions and other drugs
\n
\n
\n
\n \n